Neck cellulitis complicating spectacle frames' contact dermatitis: A case report. [PDF]
Hamdan R+5 more
europepmc +1 more source
Plastics in dermatology: A review and solutions
This review explores the environmental and health impacts of plastics, particularly microplastics in dermatological products. It discusses the plastic life cycle, routes of exposure, health risks and provides science‐based recommendations to reduce plastic use in dermatology.
Eugene Tan, Susanne Saha, Dennis Niebel
wiley +1 more source
Recognizing Dupilumab-Associated Head and Neck Dermatitis in Skin of Color: A Case Series. [PDF]
Shan DM, Riley M, Milgraum DM.
europepmc +1 more source
A post hoc analysis of Severity of Alopecia Tool (SALT) score trajectories in patients with alopecia areata who received ritlecitinib 50 mg once‐daily in ALLEGRO‐2b/3 and rolled over into the ongoing, open‐label, Phase 3 ALLEGRO‐LT study. Long‐term response patterns up to Month 24 and variables associated with treatment response are described. Abstract
B. King+15 more
wiley +1 more source
ARHGAP25: a novel player in the Pathomechanism of allergic contact hypersensitivity. [PDF]
Czárán D+5 more
europepmc +1 more source
Completed suicide in patients with skin disease: A systematic review and meta‐analysis
Several skin diseases have been associated with suicidality. However, the term ‘suicidality’ encompasses ideation, which weakens the conclusions. In contrast, the much stronger endpoint of completed suicide and skin disease remains ambiguous. This was the focus of this study.
B. Hrvatin Stancic+5 more
wiley +1 more source
Eyelid Contact Dermatitis: 25-Year Single-Center Retrospective Study. [PDF]
Rubegni G+9 more
europepmc +1 more source
The Frontal Fibrosing Alopecia Syndrome: How a Single Word Name Change Might Change So Much
International Journal of Dermatology, EarlyView.
Jeffrey Donovan
wiley +1 more source
European Guideline (EuroGuiDerm) on atopic eczema: Living update
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg+31 more
wiley +1 more source
Efficacy of Lacticaseibacillus rhamnosus probiotic strains in treating chromate induced dermatitis. [PDF]
Ali M, Amin A, Abbas Z.
europepmc +1 more source